These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 230493)

  • 1. Changes in plasma lipoprotein distribution and formation of two unusual particles after heparin-induced lipolysis in hypertriglyceridemic subjects.
    Forte TM; Krauss RM; Lindgren FT; Nichols AV
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5934-8. PubMed ID: 230493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced lipolysis in hypertriglyceridemic subjects results in the formation of atypical HDL particles.
    O'Meara NM; Cabana VG; Lukens JR; Loharikar B; Forte TM; Polonsky KS; Getz GS
    J Lipid Res; 1994 Dec; 35(12):2178-90. PubMed ID: 7897316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?
    Chung BH; Segrest JP; Smith K; Griffin FM; Brouillette CG
    J Clin Invest; 1989 Apr; 83(4):1363-74. PubMed ID: 2703536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state.
    Irawati D; Mamo JC; Soares MJ; Slivkoff-Clark KM; James AP
    Atherosclerosis; 2015 Nov; 243(1):236-41. PubMed ID: 26407667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transport of triglyceride in the high-density lipoproteins of human plasma.
    Barter PJ; Connor WE
    J Lab Clin Med; 1975 Feb; 85(2):260-72. PubMed ID: 163284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change of plasma lipoproteins by heparin-released lipoprotein lipase.
    Yang JY; Kim TK; Koo BS; Park BH; Park JW
    Exp Mol Med; 1999 Jun; 31(2):60-4. PubMed ID: 10410303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of the electrophoretic pattern of type IV hyperlipidaemia to type III by intravenous heparin.
    Olsson AG; Carlson LA; Carlson K
    Acta Med Scand; 1978; 203(6):487-90. PubMed ID: 208351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.
    Patsch JR; Gotto AM; Olivercrona T; Eisenberg S
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4519-23. PubMed ID: 212757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein metabolism in familial lecithin:cholesterol acyltransferase deficiency.
    Glomset JA; Norum KR; Nichols AV; Forte T; King WC; Albers J; Mitchell CD; Applegate KR; Gjone E
    Scand J Clin Lab Invest Suppl; 1974; 137():165-72. PubMed ID: 4367614
    [No Abstract]   [Full Text] [Related]  

  • 17. High-density lipoprotein subpopulations as substrates for the transfer of cholesteryl esters to very-low-density lipoproteins.
    Lasunción MA; Iglesias A; Skottová N; Orozco E; Herrera E
    Biochem J; 1990 Sep; 270(2):441-9. PubMed ID: 2400395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicronaemia in multiple myeloma.
    Aviram M; Carter A; Brook JG; Tatarsky I
    Scand J Haematol; 1985 May; 34(5):436-41. PubMed ID: 4012223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.